Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

214

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

214 results for “immunomodulatory”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov32/100

Immunomodulatory Effect of Dexmedetomidine as an Adjuvant Drug in Laparoscopic Cholecystectomies

ClinicalTrials.gov study NCT05489900. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects

ClinicalTrials.gov study NCT00000713. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency

ClinicalTrials.gov study NCT05586737. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
zenodo28/100

Figure 1 from: Ivankiv YI, Oleshchuk OM (2020) Immunomodulatory effect of melatonin supplementation in experimental diabetes. Pharmacia 67(4): 223-228. https://doi.org/10.3897/pharmacia.67.e55437

Figure 1 Immunoglobulins A, M, G data diversity at different diabetes models with melatonin introduction. DM1 + MT – diabetes mellitus type 1 plus melatonin; DM2 + MT – diabetes mellitus type 2 plus melatonin; Ig A – immunoglobulin A; Ig M – immunoglobulin M; Ig G – immunoglobulin G; g/l – gram per liter.

opencc-by-4.0Oct 2020View details →
zenodo28/100

Antimicrobial, Probiotic, and Immunomodulatory Potential of Cannabis sativa Extract and Delivery Systems

<p>Article, Dataset for the article</p> <p>&nbsp;</p> <h2>Abstract</h2> <div>The compounds present in hemp show multidirectional biological activity. It is related to the presence of secondary metabolites, mainly cannabinoids, terpenes, and flavonoids, and the synergy of their biological activity. The aim of this study was to assess the activity of the Henola&nbsp;<span>Cannabis sativae</span>&nbsp;extract and its combinations with selected carriers (polyvinyl caprolactam&ndash;polyvinyl acetate&ndash;polyethylene glycol graft copolymer, magnesium aluminometasilicate, and hydroxypropyl-&beta;-cyclodextrin) in terms of antimicrobial, probiotic, and immunobiological effects. As a result of the conducted research, the antimicrobial activity of the extract was confirmed in relation to the following microorganisms:&nbsp;<span>Clostridium difficile</span>,&nbsp;<span>Listeria monocytogenes</span>,&nbsp;<span>Enterococcus faecalis</span>,&nbsp;<span>Staphylococcus aureus</span>,&nbsp;<span>Staphylococcus pyrogenes</span>,&nbsp;<span>Escherichia coli</span>,&nbsp;<span>Klebsiella pneumoniae</span>,&nbsp;<span>Salmonella typhimurium</span>,&nbsp;<span>Pseudomonas aereuginosa</span>, and&nbsp;<span>Candida albicans</span>&nbsp;(microorganism count was reduced from ~10<sup>2</sup>&nbsp;CFU mL<sup>&minus;1</sup>&nbsp;to &lt;10 CFU mL<sup>&minus;1</sup>&nbsp;in most cases). Additionally, for the system with hydroxypropyl-&beta;-cyclodextrin, a significant probiotic potential against bacterial strains was established for strains&nbsp;<span>Lactobacillus acidophilus</span>,&nbsp;<span>Lactobacillus casei</span>,&nbsp;<span>Lactobacillus plantarum</span>,&nbsp;<span>Lactobacillus brevis</span>,&nbsp;<span>Lactobacillus rhamnosus</span>,&nbsp;<span>Lactobacillus reuteri</span>,&nbsp;<span>Pediococcus&nbsp;pentosaceus</span>,&nbsp;<span>Lactococcus lactis</span>,&nbsp;<span>Lactobacillus fermentum</span>, and&nbsp;<span>Streptococcus thermophilus</span>&nbsp;(microorganism count was increased from ~10<sup>2</sup>&nbsp;to 10<sup>4</sup>&ndash;10<sup>7</sup>). In terms of immunomodulatory properties, it was determined that the tested extract and the systems caused changes in IL-6, IL-8, and TNF-&alpha; levels.</div> <div> <div> <div>Keywords:&nbsp;</div> <a href="https://www.mdpi.com/search?q=Cannabis+sativa"><span>Cannabis sativa</span></a>;&nbsp;<a href="https://www.mdpi.com/search?q=cannabidiol">cannabidiol</a>;&nbsp;<a href="https://www.mdpi.com/search?q=antibacterial">antibacterial</a>;&nbsp;<a href="https://www.mdpi.com/search?q=probiotic">probiotic</a>;&nbsp;<a href="https://www.mdpi.com/search?q=immunomodulatory">immunomodulatory</a>;&nbsp;<a href="https://www.mdpi.com/search?q=immunostimulatory">immunostimulatory</a></div> </div>

opencc-by-4.0Apr 2024View details →
zenodo28/100

Supplementary material 1 from: Indradi RB, Pitaloka DAE, Suryani (2022) Network pharmacology to uncover potential anti-inflammatory and immunomodulatory constituents in Curcuma longa rhizome as complementary treatment in COVID-19. Pharmacia 69(4): 995-1003. https://doi.org/10.3897/pharmacia.69.e89799

Datasets of Network Pharmacology Process

opencc-zeroNov 2022View details →
zenodo28/100

Fig. 6 in Highly oxygenated isoryanodane diterpenoids from the leaves of Cinnamomum cassia and their immunomodulatory activities

Fig. 6. Amplified HSQC spectra of diterpenoids 5 (A) and 6 (B).

opennotspecifiedApr 2022View details →
zenodo28/100

Fig. 2. 1H–1H in Highly oxygenated isoryanodane diterpenoids from the leaves of Cinnamomum cassia and their immunomodulatory activities

Fig. 2. 1H–1H COSY, key HMBC, and NOESY correlations of cinnacassin A (1).

opennotspecifiedApr 2022View details →
zenodo28/100

Fig. 3. X in Highly oxygenated isoryanodane diterpenoids from the leaves of Cinnamomum cassia and their immunomodulatory activities

Fig. 3. X-ray ORTEP drawing of cinnacassin A (1).

opennotspecifiedApr 2022View details →
ClinicalTrials.gov28/100

Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19

ClinicalTrials.gov study NCT04385849. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

ClinicalTrials.gov study NCT04769258. IPD Sharing: Not stated. Countries: 0. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

ClinicalTrials.gov study NCT05288062. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation

ClinicalTrials.gov study NCT04397796. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis

ClinicalTrials.gov study NCT00361283. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

B-cell Depletion in Offspring to Women With MS Under Immunomodulatory Treatment

ClinicalTrials.gov study NCT06711354. IPD Sharing: YES. Countries: 0. Publications: 18.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients

ClinicalTrials.gov study NCT00728936. IPD Sharing: Not stated. Countries: 2. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

A Multi-Center Study of a SCD for Immunomodulatory Dysregulation in Pediatric AKI

ClinicalTrials.gov study NCT04869787. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients

ClinicalTrials.gov study NCT03539861. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease

ClinicalTrials.gov study NCT00701129. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad28/100

Data from: The neuroendocrine immunomodulatory axis-like pathway mediated by circulating haemocytes in pacific oyster Crassostrea gigas

Open the record for dataset details and reuse information.

publicDec 2017View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.